(Q43948600)

28 November 2017

title

Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups (English)

1 reference

28 November 2017

James M Chen

1

1 reference

28 November 2017

Guixian Jin

series ordinal

2

1 reference

28 November 2017

Amy Sung

series ordinal

3

1 reference

28 November 2017

Jeremy I Levin

series ordinal

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

28 November 2017

published in

1 reference

28 November 2017

volume

12

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

1195-1198

1 reference

Cytokine pathways and joint inflammation in rheumatoid arthritis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

The therapeutic potential of small molecule TACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

The design, structure, and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Letter to the editor: 1H, 15N, 13C, and 13CO assignments and secondary structure determination of collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Structural properties of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

Spectrophotometric assay for vertebrate collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900135-X

7 January 2021

10.1016/S0960-894X(02)00135-X

Identifiers

DOI

1 reference

28 November 2017

1 reference